What the Experts Say Professional organizations like the National Eating Disorders Association (NEDA) and eating disorder treatment programs caution against prescribing GLP-1s to individuals with active or past eating disorders
Some individuals may experience mild side effects such as insomnia, changes in taste, nausea, or mood swings
[1] mhra.gov.uk or via the Yellow Card app)
Other emotional or behavioral changes that merit discussion with a healthcare provider include persistent sadness or depression lasting more than two weeks, significant anxiety that interferes with daily functioning, unusual irritability or anger, emotional numbness or detachment, marked mood swings, uncharacteristic emotional reactions, difficulty concentrating or making decisions, loss of interest in previously enjoyed activities, or social withdrawal
Chronic semaglutide treatment did not affect linear growth in these animals, consistent with clinical studies in children with obesity treated with semaglutide or liraglutide, which reported no evidence of altered growth outcomes 7,34,35